Form 4: AJG VP Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Arthur J. Gallagher & Co. Vice President Christopher E. Mead sold 1,250 shares of common stock for $250.74 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Christopher E. Mead, Vice President of Arthur J. Gallagher & Co. (AJG), reported a sale of company common stock.
- The transaction involved the disposition of 1,250 shares of common stock on November 21, 2025.
- The shares were sold at a price of $250.74 per share.
- This transaction was executed pursuant to a Rule 10b5-1(c) trading plan, indicating a pre-scheduled sale.
- Following the sale, Mr. Mead directly beneficially owns 17,326.7322 shares of common stock and indirectly owns 418.658 shares in a Gallagher 401(k) plan account.
- He also holds 2,367 shares of restricted common stock.
- Derivative holdings include 20,125.736 shares of phantom stock and 1,584.532 notional stock units, both representing rights to receive common stock.
- Additionally, Mr. Mead holds various non-qualified stock options with exercise prices ranging from $55.94 to $337.74, covering a total of 53,592 underlying common shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be perceived negatively, the fact that it was executed under a Rule 10b5-1 plan mitigates any concerns about the insider acting on non-public information. The executive retains significant holdings.
Positives
- The transaction was conducted under a Rule 10b5-1 trading plan, which suggests a pre-scheduled sale rather than a reaction to new, non-public information, often viewed as a neutral or less negative signal than an unplanned insider sale.
- Mr. Mead retains substantial direct and indirect beneficial ownership in Arthur J. Gallagher & Co. common stock, restricted stock, phantom stock, notional stock units, and a significant number of stock options, indicating continued alignment with shareholder interests.
Negatives
- An insider sale, even if pre-planned, reduces the direct equity stake of a key executive in the company.
Future Outlook
The filing does not contain specific forward-looking statements or guidance regarding the company's future performance.
Industry Context
This Form 4 filing details a routine insider transaction for an executive at a large, publicly traded insurance brokerage and risk management firm. Such transactions are common and typically do not reflect broader industry trends unless they are unusually large or frequent across multiple insiders.
Stakeholder Impact
- Shareholders: The sale is a minor reduction in an executive's direct holdings, but the pre-planned nature under Rule 10b5-1 suggests no immediate negative implications for shareholder confidence. The executive retains substantial equity exposure.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 2017-05-01 | Grant date for a non-qualified stock option with an exercise price of $55.94. |
| 2018-03-15 | Grant date for a non-qualified stock option with an exercise price of $70.74. |
| 2024-05-01 | Date when the non-qualified stock option granted on May 1, 2017, becomes exercisable. |
| 2025-02-28 | Closing price of Gallagher common stock on this date was $337.74, relevant for a non-qualified stock option. |
| 2025-03-15 | Date when the non-qualified stock option granted on March 15, 2018, becomes exercisable. |
| 2025-11-21 | Date of the reported transaction (sale of common stock). |
| 2025-11-25 | Date the Form 4 filing was signed and submitted. |
| 2026-03-14 | Expiration date for a non-qualified stock option with an exercise price of $79.59. |
| 2027-03-12 | Expiration date for a non-qualified stock option with an exercise price of $86.17. |
| 2028-03-16 | Expiration date for a non-qualified stock option with an exercise price of $127.9. |
| 2029-03-15 | Expiration date for a non-qualified stock option with an exercise price of $158.56. |
| 2030-03-15 | Expiration date for a non-qualified stock option with an exercise price of $177.09. |
| 2031-03-01 | Expiration date for a non-qualified stock option with an exercise price of $243.54. |
| 2032-03-01 | Expiration date for a non-qualified stock option with an exercise price of $337.74. |
Recommendation
holdThis Form 4 filing reports a routine, pre-planned insider stock sale by a Vice President. The transaction, executed under a 10b5-1 plan, does not suggest any new material information or a change in the company's fundamental outlook. The executive retains significant equity holdings. Therefore, this specific filing alone does not warrant a change in investment recommendation for Arthur J. Gallagher & Co., and a 'hold' recommendation remains appropriate based solely on this information.
Keywords
Arthur J. Gallagher & Co., AJG, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Executive Compensation, Common Stock, Derivative Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.